Treatment of terminal restlessness: A review of the evidence

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 18, Issue 1, 2004, Pages 5-30

  Kehl, Karen A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Benzodiazepine; Confusion; Delirium; End of life; Evidenced based; Haloperidol; Lorazepam; Midazolam; Neuroleptic; Palliative; Phenothiazine; Psychomotor agitation; Restlessness; Review; Terminal

Indexed keywords

ALPRAZOLAM; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; DEXAMETHASONE; HALOPERIDOL; HYDROMORPHONE; LEVOMEPROMAZINE; LORAZEPAM; MIDAZOLAM; MORPHINE DERIVATIVE; OLANZAPINE; PHENOBARBITAL; PROPOFOL; PSYCHOTROPIC AGENT; RISPERIDONE;

AGITATION; ANGINA PECTORIS; CLINICAL TRIAL; COCHRANE LIBRARY; CONFUSION; DRUG CHOICE; DRUG EFFICACY; EMBASE; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; HEART ARRHYTHMIA; HOSPICE CARE; HUMAN; HYPOTENSION; INJECTION PAIN; INTERNET; MEDLINE; NEUROLEPTIC MALIGNANT SYNDROME; PALLIATIVE THERAPY; PARKINSONISM; PSYCINFO; RESTLESSNESS; REVIEW; SEDATION; SYSTEMATIC REVIEW; TARDIVE DYSKINESIA; TERMINAL CARE;

EID: 2942620208     PISSN: 15360288     EISSN: None     Source Type: Journal    
DOI: 10.1080/J354v18n01_02     Document Type: Review

References (90)

1. Lichter I, Hunt E: The last 48 hours of life. J Palliat Care. 1990;6(4):7-15.
2. Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Almazor ME, Bruera ED: Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med. 2000;160(6):786-94.
3. Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T: Symptom control during the last week of life on a palliative care unit. J Palliat Care. 1991;7(1):5-11.
4. Roth AJ, Breitbart W: Psychiatric emergencies in terminally ill cancer patients. Hematol Oncol Clin N Am. 1996;10(1):235-59.
5. Hermann C, Looney, S: The effectiveness of symptom management in hospice patients during the last seven days of life. J Hosp Palliat Nurs. 2001;3(3):88-97.
6. Burke AL: Palliative care: an update on "terminal restlessness." Med J Aust. 1997;166(1):39-42.
7. Gagnon P, Allard P, Masse B, DeSerres M: Delirium in terminal cancer: a prospective study using daily screening, early diagnosis, and continuous monitoring. J Pain Symptom Manage. 2000;19(6):412-26.
8. Keen JC: Re: the use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage. 2000;19(2):80-1.
9. Jakobsson M, Strang P: [Midazolam (Dormicum) in terminal anxiety and agitation. The last choice alternative in palliative care]. Lakartidningen. 1999;96(17):2079-81.
10. Stirling LC, Kurowska A, Tookman A: The use of phenobarbitone in the management of agitation and seizures at the end of life. Journal of Pain & Symptom Management. 1999;17(5):363-8.
11. Twycross RG, Lichter I: The terminal phase, in Doyle D, Hanks GWC, MacDonald N (ed): Oxford textbook of palliative medicine. Oxford, Oxford University Press, 1993, pp. 651-61.
12. Bergevin P, Bergevin RM: Recognizing delirium in terminal patients. Am J Hosp Palliat Care. 1996;13(2):28-9.
13. Ross DD, Alexander CS: Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspnea. Am Fam Physician. 2001;64(6): 1019-26.
14. Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobson P: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry. 1996;153(2):231-7.
15. Breitbart W, Strout D: Delirium in the terminally ill. Clin Geriatr Med. 2000;16(2):357-72.
16. Caraceni A, Nanni O, Maltoni M, Piva L, Indelli M, Arnoldi E, Monti M, Montanari L, Amadori D, De Conno F: Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer. 2000;89(5):1145-9.
17. Casarett DJ, Inouye SK, American College of Physicians-American Society of Internal Medicine End-of-Life Care Consensus P: diagnosis and management of delirium near the end of life. Ann Intern Med. 2001;135(1):32-40.
18. de Stoutz ND, Tapper M, Fainsinger RL: Reversible delirium in terminally ill patients. Journal of Pain & Symptom Management. 1995;10(3):249-53.
19. Fainsinger RL, De Moissac D, Mancini I, Oneschuk D: Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care. 2000; 16(2):5-10.
20. Fainsinger RL, Tapper M, Bruera E: A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliat Care. 1993;9(3):4-8.
21. Lawlor PG, Fainsinger RL, Bruera ED: Delirium at the end of life: critical issues in clinical practice and research. JAMA. 2000;284(19):2427-9.
22. Macleod AD: Clinical management. The management of delirium in hospice practice. Eur J Palliat Care. 1997;4(4):116-20.
23. Jackson KC, Lipman, AG: Delirium in palliative care patients. Journal of Pharmaceutical Care in Pain and Symptom Control. 2000;7(4):59-71.
24. Burke AL, Diamond PL, Hulbert J, Yeatman J, Farr EA: Terminal restlessness-its management and the role of midazolam. Med J Aust. 1991;155(7):485-7.
25. Back I: Terminal restlessness in patients with advanced malignant disease. Palliat Med. 1992;6:293-8.
26. Collins PD, Poole K: Terminal restlessness-its management and the role of midazolam. Med J Aust. 1992;156(2):141.
27. Jacobs WM, Thiesbrummel AW, Zylic Z: [Treatment of restlessness in dying patients: more than just sedation]. Ned Tihdschr Geneeskd. 1998;142(9):433-6.
28. Krajnik M, Zylicz Z: Terminal restlessness and nicotine withdrawal. Lancet. 1995;346(8981):1044.
29. Kuebler K: Hospice and palliative care clinical practice protocol: Terminal restlessness. Pittsburgh, PA, Hospice and Palliative Nurses Association, 1997, pp. 1-30.
30. Travis SS, Conway J, Daly M, Larsen P: Terminal restlessness in the nursing facility: assessment, palliation and symptom management. Geriatr Nurs. 2001;22(6): 308-12.
31. March PA: Terminal restlessness. Am J Hosp Palliat Care. 1998;15(1):51-3.
32. Boyle DM, Abernathy G, Baker L, Wall AC: End-of-life confusion in patients with cancer. Onc Nurs Forum. 1998;25(8):1335-43.
33. Shuster JL, Jr., Breitbart W, Chochinov HM: Psychiatric aspects of excellent end-of-life care. Ad Hoc Committee on End-of-Life Care. The Academy of Psychosomatic Medicine. Psychosomatics. 1999;40(1):1-4.
34. Sivesind D, Baile WF: The psychologic distress in patients with cancer. Nurs Clin North Am. 2001;36(4):809-25, viii.
35. Levy MH, Catalano RB: Control of common physical symptoms other than pain in patients with terminal disease. Sem Oncol. 1985;12(4):411-30.
36. Voltz R, Borasio GD: Palliative therapy in the terminal stage of neurological disease. J Neurol. 1997;244(Suppl 4):S2-10.
37. Mercadante S, De Conno F, Ripamonti C: Propofol in terminal care. Journal of Pain & Symptom Management. 1995;10(8):639-42.
38. Moyle J: The use of propofol in palliative medicine. Journal of Pain & Symptom Management. 1995;10(8):643-6.
39. McIver B, Walsh D, Nelson K: The use of chlorpromazine for symptom control in dying cancer patients. Journal of Pain & Symptom Management. 1994;9(5):341-5.
40. Twaddle ML: The process of dying and managing the death event. Primary Care; Clinics in Office Practice. 2001;28(2):329-38.
41. Cowan JD: The dying patient. Curr Oncol Rep. 2000;2(4):331-7.
42. O'Neill J, Fountain A: Levomepromazine (methotrimeprazine) and the last 48 hours. Hosp Med. 1999;60(8):564-7.
43. Fainsinger R, Bruera E: Treatment of delirium in a terminally ill patient. J Pain & Symptom Management 1992;7(1):54-6.
44. Stiefel F, Fainsinger R, Bruera E: Acute confusional states in patients with advanced cancer. Journal of Pain & Symptom Management. 1992;7(2):94-8.
45. Stiefel F, Berney A, Mazzocato C: Psychopharmacology in supportive care in cancer: a review for the clinician. I. Benzodiazepines. Support Care Cancer. 1999;7(6): 379-85.
46. Bottomley DM, Hanks GW: Subcutaneous midazolam infusion in palliative care. Journal of Pain & Symptom Management. 1990;5(4):259-61.
47. Stone P, Rees E, Hardy JR: End of life care in patients with malignant disease. Eur J Cancer. 2001;37(9):1070-5.
48. Nunez-Olarte JM: Opioid-induced myoclonus. Eur J Palliat Care. 1995(2): 146-50.
49. Dunlop RJ: Is terminal restlessness sometimes drug induced? Palliat Med. 1989;3:65-6.
50. McNamara P, Minton M, Twycross RG: Use of midazolam in palliative care. Palliat Med. 1991(5):244-9.
51. Smales OR, Smales EA, Sanders HG: Flunitrazepam in terminal care. Journal of Paediatrics & Child Health. 1993;29(1):68-9.
52. Ramani S, Karnad AB: Long-term subcutaneous infusion of midazolam for refractory delirium in terminal breast cancer. South Med J. 1996;89(11):1101-3.
53. Quinn K, Flynn, E: Understanding confusion in palliative care patients. CPC News-Centre for Palliative Care, 2000;2:4-6.
54. Twycross RG: Symptom control: the problem areas. Palliat Med. 1993(7 (Suppl 1):1-8.
55. Caraceni A: Delirium in palliative medicine. Eur J Palliat Care. 1995;2:62-6.
56. Frederich ME: Nonpain symptom management. Primary Care; Clinics in Office Practice. 2001;28(2):299-316.
57. Martin EW: Confusion in the terminally ill: recognition and management. Am J Hosp Palliat Care. 1990;7(3):20-4.
58. Bruera E, Neumann CM: Management of specific symptom complexes in patients receiving palliative care. CMAJ (Canadian Medical Association Journal). 1998; 158(13):1717-26.
59. Emanuel LL, von Gunten CF, Ferris FD: EPEC participant's handbook: Depression, anxiety, delirium, RWJ Foundation. 1999; vol. 6, pp. 1-13.
60. Mazzocato C, Stiefel F, Buclin T, Berney A: Psychopharmacology in supportive care of cancer: a review for the clinician: II. Neuroleptics. Support Care Cancer. 2000;8(2):89-97.
61. Stiefel F, Razavi D: Common psychiatric disorders in cancer patients. II. Anxiety and acute confusional states. Support Care Cancer. 1994;2(4):233-7.
62. Zimberg M, Berenson S: Delirium in patients with cancer: nursing assessment and intervention. One Nurs Forum. 1990;17(4):529-38.
63. Dymock B, MacConnachie A: Relief of Pain and Related Symptoms. Edinburgh, Scotland, Scottish Partnership Agency for Palliative and Cancer Care, 2000, pp. 1-44.
64. Slade D, deKock I, Fainsinger R: Death with dignity: Sedation for intractable symptoms in the home, Home Health Care Consultant, 2002.
65. Trzepacz PT, Breitbart W, Franklin J, et al.: American Psychiatric Association practice guidelines: practice guidelines for the treatment of patients with delirium. Am J Psychiatry. 1999;156(Supplement 5):1-20.
66. Fainsinger RL, Landman W, Hoskings M, Bruera E: Sedation for uncontrolled symptoms in a South African hospice. Journal of Pain & Symptom Management. 1998;16(3):145-52.
67. Massie MJ, Holland J, Glass E: Delirium in terminally ill cancer patients. Am J Psychiatry. 1983;140(8):1048-50.
68. Pereira J, Hanson J, Bruera E: The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer. 1997;79(4):835-42.
69. Bruera E, Miller L, McCallion J, Macmillan K, Krefting L, Hanson J: Cognitive failure in patients with terminal cancer: a prospective study. Journal of Pain & Symptom Management. 1992;7(4):192-5.
70. Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY: Sedation for refractory symptoms of terminal cancer patients in Taiwan. Journal of Pain & Symptom Management. 2001;21(6):467-72.
71. Inouye SK: Does delirium contribute to poor hospital outcomes?: a three-site epidemiological study. J Gen Intern Med. 1998;13(4):234-42.
72. Inouye SK, Foreman MD, Mion LC, Katz KH, Cooney LM, Jr.: Nurses' recognition of delirium and its symptoms: comparison of nurse and researcher ratings. Arch Intern Med. 2001;161(20):2467-73.
73. Trzepacz PT: Delirium. Advances in diagnosis, pathophysiology, and treatment. Psychiatr Clin North Am. 1996;19(3):429-48.
74. Quill TE, Byock IR: Responding to intractable terminal suffering: the role of terminal sedation and voluntary refusal of food and fluids. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med. 2000;132(5):408-14.
75. Milisen K, Foreman MD, Godderis J, Abraham IL, Broos PL: Delirium in the hospitalized elderly: nursing assessment and management. Nurs Clin North Am. 1998;33(3):417-39.
76. Inouye SK: Delirium in hospitalized older patients. Clin Geriatr Med. 1998; 14(4):745-64.
77. Breitbart W, Jacobsen PB: Psychiatric symptom management in terminal care. Clin Geriatr Med. 1996;12(2):329-47.
78. Delirium, National Cancer Institute, 2002.
79. Lipowski ZJ: Delirium in the elderly patient. New Engl J Med. 1989;320(9): 578-82.
80. Inouye SK: The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med. 1994;97(3):278-88.
81. Foreman MD: Acute confusion in the elderly. Annu Rev Nurs Res. 1993; 11:3-30.
82. Hardy J: Sedation in terminally ill patients. Lancet. 2000;356(9245):1866-7.
83. Foreman MD, Zane D: Nursing strategies for acute confusion in elders. Am J Nurs. 1996;96(4):44-51; quiz 51-2.
84. Rousseau P: The ethical validity and clinical experience of palliative sedation: Mayo Clinic Proceedings, Mayo Foundation for Medical Education and Research, 2000.
85. Foreman MD, Mion LC, Tryostad L, Fletcher K: Standard of practice protocol: acute confusion/delirium. NICHE Faculty. Geriatr Nurs. 1999;20(3):147-52.
86. Doyle D, Woodruff R: Manual of the IAHPC, International Association for Hospice and Palliative Care, 2002.
87. Wrede-Seaman L: Symptom Management Algorithms for Palliative Care. Yakima, WA, Intellicard, 1996: vol. 1.
88. Bruera E, Neumann CM: The uses of psychotropics in symptom management in advanced cancer. Psychooncology. 1998;7(4):346-58.
89. Association AP: Diagnostic and statistical manual of mental disorders. Washington, DC, American Psychiatric Association, 1994, pp. 122-33.
90. Morita T, Tei Y, Tsunoda J, Inoue S, Chihara S: Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain & Symptom Management 2001;22(6):997-1006.